NCT07042503Not yet recruiting
Effects of Different Preoperative Oral Rehydration Protocols in Undergoing Thoracoscopic Radical Lung Cancer Surgery
Effects of Different Preoperative Oral Rehydration Protocols on Safety, Comfort, and Postoperative Outcomes in Elderly Patients Undergoing Thoracoscopic Radical Lung Cancer Surgery: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 29 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to compare the new preoperative oral rehydration protocol (administering 50-100 mL of clear fluids or carbohydrate-rich beverages orally every hour until the patient arrives at the operating room) with the traditional preoperative protocol (consuming 200-300 mL of water orally two hours prior to surgery). The objective is to investigate the effects of these two protocols on the safety (e.g., risk of reflux and aspiration), comfort (e.g., levels of hunger, thirst, and anxiety), gastric emptying status (as assessed by gastric ultrasound indicators), and postoperative outcomes (e.g., incidence of postoperative delirium, insulin resistance, and inflammatory factor levels) in elderly patients undergoing thoracoscopic lung cancer radical surgery. This research seeks to identify a more appropriate preoperative rehydration protocol for elderly lung cancer patients.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 420 (estimated)
- First submitted
- 16 Jun 2025
- Start date
- 1 Jul 2025
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Fujian Medical University Union Hospital
- Diseases
- Lung cancer
- NCT number
- NCT07042503
What you commit to
- Study type: Observational
- Planned participants: 420
- From 1 Jul 2025 to the primary completion date, 1 Jul 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Had received treatments such as radiotherapy and chemotherapy before the surgery that might affect the research indicators.
Other illness
- Combined with severe functional impairments of important organs such as the heart, liver, and kidneys.
- Suffering from metabolic diseases such as diabetes and hyperthyroidism.
- Having digestive system diseases such as gastric emptying disorders, dysphagia, and intestinal obstruction.
- Allergic or intolerant to carbohydrates.
- Patients with mental disorders or cognitive dysfunction.
Who the study is looking for
- Elderly patients aged 65 or above who are scheduled to undergo thoracoscopic radical lung cancer surgery.
- American Society of Anesthesiologists (ASA) classification levels II-III.
- No severe cognitive impairment (Mini-Mental State Examination (MMSE) score ≥ 24).
- Able to cooperate with the study and sign the informed consent form.
Age in the registry: 65 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.